Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of UDCA Supplementation on Liver Regeneration in Adult LDLT Recipients
NCT07664020Not yet recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jun 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Randomised trial in chronic liver disease (CLD) comparing Ursodeoxycholic acid+standard medical treatment with Placebo+standard medical treatment (2 arms). Primary endpoints: Regenerated liver volume and Regeneration Liver Indices. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
chronic liver disease (CLD)
Beyond the preview
Go deeper on NCT07664020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07664020.